sulfasalazine has been researched along with Diathesis in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Y | 1 |
Yang, Q | 1 |
Liao, M | 1 |
Wang, H | 1 |
Zhang, C | 1 |
Nambi, S | 1 |
Wang, W | 1 |
Zhang, M | 1 |
Wu, J | 1 |
Deng, G | 1 |
Deng, Q | 1 |
Liu, H | 1 |
Zhou, B | 1 |
Jin, Q | 1 |
Feng, CG | 1 |
Sassetti, CM | 1 |
Wang, F | 1 |
Chen, X | 1 |
1 other study available for sulfasalazine and Diathesis
Article | Year |
---|---|
xCT increases tuberculosis susceptibility by regulating antimicrobial function and inflammation.
Topics: Amino Acid Transport System y+; Animals; Anti-Infective Agents; Case-Control Studies; Cell Line, Tum | 2016 |